Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
DNA Vaccination
60%
DNA Immunization
60%
Drug Resistance
39%
Reverse Transcriptase
38%
Human Immunodeficiency Virus
34%
Antigen
32%
Integrase
30%
Upregulation
30%
Immunity
30%
Adoptive Immunity
30%
Cladistics
30%
Tumor Cell
15%
Cell Motility
14%
Syngenic
14%
Prevalence
14%
Lipid Peroxidation
14%
Cell Migration
14%
Mammary Gland
14%
Splenocyte
12%
Wound Healing Assay
9%
HIV/AIDS
9%
Human Immunodeficiency Virus Type 1 Subtype A
9%
T Cell
7%
Bagg Albino Mouse
7%
Lentivirus Vector
7%
Immunotherapy
6%
Interleukin 2
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
69%
DNA Immunization
60%
Adenocarcinoma
41%
Metastasis
37%
Tumor Growth
37%
Drug Resistance
36%
RNA Directed DNA Polymerase
33%
Antigen
32%
Carcinogenicity
32%
Proteinase
30%
Human Immunodeficiency Virus 1 Infection
30%
Human Immunodeficiency Virus Proteinase
30%
Integrase
30%
Reactive Oxygen Metabolite
30%
Human Immunodeficiency Virus 1
30%
Neoplasm
16%
Prevalence
9%
Carcinogenesis
9%
Malignant Neoplasm
7%
Malignant Transformation
7%
Nucleoside
6%
Human Immunodeficiency Virus Type 1 Subtype A
6%
Ribonuclease
6%
Nonhodgkin Lymphoma
6%
Vimentin
6%
Uterine Cervix Cancer
6%
Wound Healing
6%
Kaposi Sarcoma
6%
Virus Infection
6%
Lentivirus Vector
5%
Bagg Albino Mouse
5%
CD8 Antigen
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
97%
Tumor Progression
38%
Drug Resistance
37%
Reverse Transcriptase
34%
Human Immunodeficiency Virus
34%
Integrase
30%
Cellular Immunity
30%
HIV-1 Protease
30%
Protease
30%
Upregulation
30%
Cladistics
30%
Immunity
24%
Carcinogenesis
11%
Cell Motility
11%
Syngenic
11%
Lipid Peroxidation
11%
Prevalence
11%
Cell Migration
11%
T Cell
9%
Malignant Transformation
8%
Vimentin
7%
Nucleoside
7%
Polymerase
7%
RNase H
7%
Wound Healing Assay
7%
Human Immunodeficiency Virus Type 1 Subtype A
7%
Splenocyte
6%
Bagg Albino Mouse
5%
Lentivirus Vector
5%